Association of Recipient APOL1 Kidney Risk Alleles With Kidney Transplant Outcomes.

Roy, Neil; Morales-Alvarez, M Catalina; Anis, Karim H; Goral, Simin; Doria, Cataldo; Kopp, Jeffrey B; Winkler, Cheryl A; Feng, Rui; Rosas, Sylvia E

Roy, Neil; Morales-Alvarez, M Catalina; Anis, Karim H; Goral, Simin; Doria, Cataldo; Kopp, Jeffrey B; Winkler, Cheryl A; Feng, Rui; Rosas, Sylvia E.

Afiliação

Roy N; Kidney and Hypertension Unit, Joslin Diabetes Center, Boston, MA.
Morales-Alvarez MC; Nephrology Department, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Anis KH; Kidney and Hypertension Unit, Joslin Diabetes Center, Boston, MA.
Goral S; Nephrology Department, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Doria C; Kidney and Hypertension Unit, Joslin Diabetes Center, Boston, MA.
Kopp JB; Nephrology Department, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Winkler CA; Division of Renal, Electrolyte, and Hypertension, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
Feng R; Capital Health Cancer Center, Pennington, NJ.
Rosas SE; Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney, National Institutes of Health, Bethesda, MD.

Transplantation ; 107(12): 2575-2580, 2023 Dec 01.

Article em En | MEDLINE | ID: mdl-37527489

Assuntos

Transplante de Rim; Humanos; Transplante de Rim/efeitos adversos; Alelos; Apolipoproteína L1/genética; Rim; Doadores de Tecidos; Sobrevivência de Enxerto/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google